Home
Onesource Specialty Pharma Ltd Board of Directors
From Blinkx's GPT

OneSource Specialty Pharma Ltd
NSE: ONESOURCE
Share Price
Last Ten Days Market Price
Date | |
---|---|
12 Mar 2025 | 1507.25 |
11 Mar 2025 | 1509.4 |
10 Mar 2025 | 1492.05 |
07 Mar 2025 | 1416.4 |
06 Mar 2025 | 1443.5 |
05 Mar 2025 | 1439.65 |
04 Mar 2025 | 1384.1 |
03 Mar 2025 | 1326.4 |
28 Feb 2025 | 1236.85 |
27 Feb 2025 | 1291.25 |
Company Fundamentals for OneSource Specialty Pharma Ltd
Market Cap
17,248 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
41.8
Day’s High
1522.0
Day’s Low
1464.45
DTE
1.5
ROE
-41.0
52 Week High
1754.0
52 Week Low
1163.05
ROCE
-4.7
Market Price of OneSource Specialty Pharma Ltd
1M
1Y
3Y
5Y
Monitoring OneSource Specialty Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
OneSource Specialty Pharma Ltd News Hub
OneSource Specialty Pharma to convene board meeting
OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on 29 Januar
Read more
25 Jan 25
Shares of Onesource Specialty Pharma list in T Group
The equity shares of Onesource Specialty Pharma (Scrip Code: 544292) are listed effective 24 January
Read more
24 Jan 25
OneSource Specialty Pharma reports consolidated net loss of Rs 68.85 crore in the December 2024 quarter
Net Loss of OneSource Specialty Pharma reported to Rs 68.85 crore in the quarter ended December 2024
Read more
29 Jan 25
Popular Search
FAQs for Board of Directors of OneSource Specialty Pharma Ltd
How are members of OneSource Specialty Pharma Ltd Board of Directors selected?
Members of the OneSource Specialty Pharma Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with OneSource Specialty Pharma Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the OneSource Specialty Pharma Ltd Board of Directors?
Shareholders can interact with the OneSource Specialty Pharma Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the OneSource Specialty Pharma Ltd Board of Directors meet?
The OneSource Specialty Pharma Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the OneSource Specialty Pharma Ltd Board of Directors?
The OneSource Specialty Pharma Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at OneSource Specialty Pharma Ltd?
The current Board of Directors at OneSource Specialty Pharma Ltd includes a mix of executive and non-executive members. The full list can be found on OneSource Specialty Pharma Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.